fbpx
All about COVID19 - An initiative from WhiteCoats that brings together updates from top curated resources exclusively for healthcare professionals

With businesses reopening, controlling the spread of the virus in air-conditioned spaces was urgent and considered smart. The research suggested that the virus remained in the air for about 3 hours and filtering the air seemed like a better plan. In collaboration with a few other scientists, researchers from the University of Houston have designed a "catch and kill" air ...

After securing an FDA go-ahead, Gilead Sciences has started testing of an inhaled formulation of its COVID-19 drug “remdesivir” in 60 healthy volunteers in the US. It is expected that this inhaled formulation should reach the outpatient setting where patients have less severe disease and with early treatment, hospitalization could be avoided. In the large-scale ACTT-1 study conducted by the ...

Most cases of COVID-19 have occurred in adults and scientists thought that it wouldn’t appear in kids or they would have an asymptotic approach. But a recent study published preprint medRxiv in July 2020 brings to light clusters of a new hyperinflammatory condition seen among children living in areas with epidemic disease. The study deals with the disease process and ...

Scientists and researchers of Queensland University of Technology and Oxford University are working in collaboration to begin clinical trials for corticosteroids, commonly used for asthma patients, on patients suffering from COVID-19.  The novel coronavirus or SARS-CoV-2 has infected over 11.79 million people around the world and killed over 543,000 individuals to date. It has led to severe complications in some ...

Research reports from the journal “Cell” suggest that a specific change in the coronavirus genome previously associated with increased viral transmission and the spread of COVID-19 is more infectious in cell culture.  The variant makes a small but effective change in the virus's 'Spike' protein, which the virus uses to enter human cells. A  theoretical biologist, Bette Korber from Los ...

The rise of COVID-19 cases around the world has paved a way to create a need for prevention that can at least decrease/ prevent the worst symptoms of SARS-CoV-2. There is growing evidence of clinical trials for immunity booster and that vaccines like BCG could help with the same. A new report published in the American Society for Microbiology’s journal ...

Asian stock markets followed Wall Street higher Thursday as hopes for the development of a coronavirus vaccine competed with concern about rising US infections. Benchmarks in many cities including Shanghai, Tokyo, Hong Kong, and countries like Australia all advanced. Investors were encouraged after Pfizer and BioNtech announced preliminary data from a vaccine test, one of a series being carried out ...

London stocks rose in early trade on Thursday amid hopes of a potential coronavirus vaccine, as investors eyed the release of the latest US non-farm payrolls report. At 0840 BST, the FTSE 100 was up 0.7% at 6,198.43. The sentiment was underpinned by news that an experimental Covid-19 vaccine from Pfizer and BioNtech produced positive antibody results. Neil Wilson, chief ...

With a vigorous increase in vaccine trials around the globe, developing countries face a different challenge. Protestors in Africa gather around the University of the Witwatersrand in Johannesburg in South Africa on Wednesday reflecting long-running fears against the trials over testing drugs on people who do not understand the risks related to it even though the volunteers were given an ...

The recent outbreak of the disease COVID-19 has rattled the population all over the world. Studying the early transmission dynamics of the infection and evaluating the control measures being taken is an absolute necessity required for assessing the potential of transmission to occur in new areas. The first outbreak in almost all countries had a history of travel to Wuhan ...